The genus Neisseria contains two species of clinical importance: Neisseria gonorrhoeae and Neisseria meningitidis. Although these two microorganisms are closely related genetically, the diseases they produce differ greatly. N. gonorrhoeae is the etiologic agent of gonorrhea, currently among the most common of the classical sexually transmitted diseases, whereas N. meningitidis is the causative agent of meningococcal meningitis. Although these Neisseria species have been known for over a century and there are effective antibiotic therapies for both of these diseases, the morbidity and mortality associated with them remain significant. For example, the pediatric mortality of meningococcal infection places it among the top 10 leading causes of death of children in North America. Similarly, the number of cases of gonorrhea reported to the Centers for Disease Control has averaged about three-quarters of a million per year for the past several years.
Despite a number of studies, the immunological mechanisms responsible for providing antigonococcal protection have been completely elucidated. In part, this is due to the lack of an animal model for studying gonococcal infection. Equally important, however, is the fact that most studies have concentrated on the systemic immune response to gonococcal infection (19, 25, 32, 37, 38) , whereas the initiation of the infection occurs locally in a site apparently isolated from these circulating immune modalities. Thus, to completely understand antigonococcal immunity, it is necessary to study the local immune responses available at or near mucosal surfaces in the male and female reproductive tracts.
Serum antibodies specific for a variety of surface antigens have been described in both meningococcal and gonococcal infections, and in some cases the presence of these antibodies can be correlated with resistance to infection. It has been proposed that these antibodies could be involved in complement-mediated bacteriolysis or opsonization of the microorganisms or both. Although these mechanisms may be important in providing systemic immunity, sites where the Neisseria spp. are commonly found (the nasopharynx and reproductive tract) are sparsely populated with phagocytes and are deficient in many of the components of complement.
Recently, an increasing number of reports suggest that beside macrophage-dependent activities, cell-mediated responses such as cytotoxic T are present in large numbers in the epithelium and the lamina propria of musocal tissue and are able to exert their functional activity at this level. NK cells and ADCC appear to be manifestations of different functions of the same lymphocyte, and it has been suggested that intestinal large granular lymphocytes may play a role in the antibacterial secretary immunoglobulin A (sIgA)-dependent ADCC (13) . A second, well characterized class of lymphocytes, the cytotoxic T lymphocytes, also may exist in musocal sites and may be active in providing antibacterial immunity. Most of these studies of cytotoxic mechanisms have focused on one or another of these distinct cell types, which have clear differences in the way they recognize target cells. It is the purpose of this paper to review recent evidence on cell-mediated immune (CMI) responses to pathogenic Neisseria spp. and to reevaluate their role in the development of antibacterial immunity.
HOST CELLULAR DEFENSES IN GONOCOCCAL INFECTION CMI Response to Gonococcal Infections
A few early reports in the literature suggest that a CMI response occurs in patients with gonococcal infection (1, 2, 5, 12, 31 ). An initial report of a delayed-type hypersensitivity response to gonococcal infection was published by Teague and Torrey (36) . During the 1930s and 1940s, delayed-type hypersensitivity was demonstrated in individuals infected with gonococci by using a variety of cellular fractions and culture filtrates (1, 2, 5) . Much of this work was done with the intent of developing a better method to diagnose the disease. Results of these studies indicated that most infected patients gave a positive result and up to 86% of normal individuals had a negative response (5) . In the 1970s, interest was generated in the CMI response to gonococcal infection. Reports of lymphocyte transformation in gonorrhea (7, 11, 17) Kannungo and Agarwal (15), using a guinea pig subcutaneous chamber model, studied the development of cellular immunity by using lymphocyte and macrophage migration as measurements of CMI. They infected the subcutaneous chambers of guinea pigs with gonococci. At 1 week postinfection there were indications of CMI, which then persisted for up to 7 weeks. The CMI response was detected by using a crude soluble cellular antigen, crude lipopolysaccharide (LPS), and a ribonucleic acid protein antigen prepared from a local clinical isolate. Koostra et al. (16) (14) . Gonococcal ribosomal ribonucleic acid, ribosomal protein, cell, walls, and pili required higher concentrations to obtain a positive skin test than did intact ribosomes. Kwapinski and Chong (18) used purified gonococcal antigens to elicit a CMI in rabbits. A nontoxic protein called B(-/+) was isolated from the cytoplasm of type 1 gonococci. B (-/+) was used to immunize rabbits prior to challenge with live gonococci in the anterior chamber of the eye. The corneas became cloudy within 24 to 48 h, and this was followed by a profuse discharge from the conjunctiva. By day 4 or 5 postinfection, the corneas were clear. In addition, the gonococci thrived when anti-B (-/+) antiserum was injected along with live gonococci into the anterior chamber of the eye.
HOST CELLULAR DEFENSES IN MENINGOCOCCAL INFECTION
Immunity to meningococcal infection is thought to depend primarily on the presence of bactericidal antibody. The production of this protective antibody follows natural infection (9) and vaccination with meningococcal polysaccharide antigens. Subjects who do not possess bactericidal antibody are at ritk of developing meningococcal disease (6) . Little attention has been paid to the possible protective role of CMI in this infection because of the evidence suggesting a dominant role for antibody in protection against meningococcal disease.
Meningococcal CMI Response Greenwood et al. (10) studied the CMI response in patients with group A meningococcal meningitis and in normal subjects given group A meningococcal vaccine. They found that lymphocyte responsiveness to both phytohemagglutinin and meningococcal antigens was markedly depressed in patients with acute meningococcal infections. This defect was present whether lymphocytes were cultured in autologous or fetal calf serum. Patients also showed a transient increase in the degree of inhibition produced by group A meningococci in leukocyte migration assays. Meningococci of other groups produced a similar degree of inhibition. Vaccination with group A meningococcal polysaccharide vaccine had no effect on lymphocyte responsiveness to meningococcal antigens or on the inhibitory effect of group A meningococci on leukocyte migration. These negative results must be interpreted carefully, since patients with acute meningococcal meningitis had positive leukocyte inhibition test results which were greater than those seen in recovered patients. Thus, there appears to be a difference in the level of responsiveness depending on the degree of antigenic stimulation.
ADCC and NK Cell Activity against Meningococci Lowell et al. (20) reported that heat-inactivated serum samples from adults immunized with group C meningococcal polysaccharide vaccine, in cooperation with normal human peripheral blood mononuclear cells, could significantly decrease the viability of group C meningococci. Of the mononuclear-cell populations, K lymphocytes (null cells) and monocytes, but not T or B lymphocytes, were capable of effecting ADCC antimeningococcal activity in this system. The degree of killing in this system was dependent on the incubation time of the reactants, the concentration of the effector cells, and the amount of antiserum used in the assay. When specific antimeningococcal antibodies were absorbed from the serum, ADCC activity was abolished. ADCC antimeningococcal activity was also temperature dependent and could be abolished either by performing the assay at 40C
or by heating the effector cells to 460C for 15 min prior to the start of the assay. Their data suggest that K cells may play a role in the host immune defense against certain bacterial pathogens. Smith and Lowell (33) reported that ADCC antimeningococcal activity was inhibited when human immune serum was preincubated with the polysaccharide of the immunizing vaccine. Furthermore, the activity against group A meningococci that was induced by heat-inactivated human immune serum was also inhibited by preincubation with that polysaccharide. Neither heterologous polysaccharide nor homologous protein or LPS meningococcal antigens inhibited the activity of either of these sera. Antibodies responsible for ADCC activity against the group C meningococci are also directed against the polysaccharide. The results of these inhibition experiments are, therefore, consistent with those of Roberts (27) , who found that opsonophagocytosis of group C and A meningococci by neutrophils in cooperation with sera taken after immunization with group C and group A meningococcal polysaccharides, respectively, was totally inhibited by the homologous polysaccharide. Owing to natural exposure and carriage, most sera of adult humans contain antibodies to both capsular and subcapsular (protein and LPS) meningococcal antigens (9, 40) . However, in contrast to the inhibitory action of the polysaccharide, homologous protein and LPS antigens were not inhibitory in this system. These data should not be interpreted as indicating that antibodies to protein and LPS antigens are incapable of inducing ADCC, since blocking the action of antibodies to protein or LPS would still leave antibodies to polysaccharide functionally available in the sera. The data do support the conclusion that if the antibodies to subcapsular LPS or protein are effective in ADCC, they must be of low titer, since blocking of antibodies to polysaccharide did not reveal antibacterial activity. This implies that, since ADCC activity occurs in the absence of added complement, this mechanism may be important to host immune defenses in areas where complement components are relatively low or nonfunctional, such as secretary surfaces including the nasopharynx and the respiratory, intestinal, and urogenital mucosa.
To compare the efficacies of the various immunoglobulin isotypes in ADCC against meningococci, Lowell et (10, 26, 34, 35) and delayed-type hypersensitivity in guinea pigs (26 infection with Neisseria spp. This includes reports both on the classical manifestations of CMI, such as delayed-type hypersensitivity skin testing, in vitro lymphocyte transformation, and production of soluble lymphokines, as well as more contemporary studies on the activity of cells involved in ADCC and NK cell activity. These reports have been overshadowed by the large number of studies suggesting that immunity to these bacteria is antibody mediated through either complement activation or opsonization. There are several observations which argue against the simplistic notion that only humoral immunity is involved in protecting an individual against infection. These are as follows. (i) Most of the studies of the role of antibody in these infections have been done with immune serum. However, both gonococci and meningococci produce local infections, where serum antibody may not be present. (ii) Complement is deficient or present in only low concentrations in areas where these two species initiate their infections. Furthermore, the predominant immunoglobulin present in the genitourinary tract (for gonococci) and the nasopharynx (for meningococci) is of an isotype (IgA) that does not fix complement. (iii) Antibodies specific for gonococci can be isolated from serum samples of individuals with histories of multiple uncomplicated gonococcal infections. The fact that these individuals develop multiple infections while this antibody is present argues against the postulate that this antibody is protective. Early work on CMI in these infections demonstrated no consistent correlation between the development of specifically sensitized cells and protection. More recent investigations of the ability of human lymphocytes to participate in NK-cell and ADCC activities against gonococci and meningococci suggest that we need to reevaluate the conclusions on the identity of protective immune mechanisms to these two bacteria. This is particularly important as efforts are undertaken to develop new, more effective vaccines for the diseases caused by these organisms.
